A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years
Clinical trial NCT05522829 · UNKNOWN
Trial details
- NCT number
- NCT05522829
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-15
- Primary completion
- 2022-12-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.